Clinical practice: Low HDL cholesterol levels

被引：130

作者：

Ashen, MD ^{[1
]}

Blumenthal, RS ^{[1
]}

机构：

[1] Johns Hopkins Univ Hosp, Johns Hopkins Ciccarone Prevent Cardiol Ctr, Baltimore, MD 21287 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2005年 / 353卷 / 12期

关键词：

D O I：

10.1056/NEJMcp044370

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1252 / 1260

页数：9

共 56 条

[41] Relation of gemfibrozil treatment and lipid levels with major coronary events - VA-HIT: A randomized controlled trial [J].

Robins, SJ ;

Collins, D ;

Wittes, JT ;

Papademetriou, V ;

Deedwania, PC ;

Schaefer, EJ ;

McNamara, JR ;

Kashyap, ML ;

Hershman, JM ;

Wexler, LF ;

Rubins, HB .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (12) :1585-1591

[42] Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol [J].

Rubins, HB ;

Robins, SJ ;

Collins, D ;

Fye, CL ;

Anderson, JW ;

Elam, MB ;

Faas, FH ;

Linares, E ;

Schaefer, EJ ;

Schectman, G ;

Wilt, TJ ;

Wittes, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (06) :410-418

[43] Ragaglitazar improves glycemic control and lipid profile in type 2 diabetic subjects - A 12-week, double-blind, placebo-controlled dose-ranging study with an open pioglitazone arm [J].

Saad, MF ;

Greco, S ;

Osei, K ;

Lewin, AJ ;

Edwards, C ;

Nunez, M ;

Reinhardt, RR .

DIABETES CARE, 2004, 27 (06) :1324-1329

[44] Metabolic basis of high density lipoproteins and apolipoprotein A-I increase by HMG-CoA reductase inhibition in healthy subjects and a patient with coronary artery disease [J].

Schaefer, JR ;

Schweer, H ;

Ikewaki, K ;

Stracke, H ;

Seyberth, HJ ;

Kaffarnik, H ;

Maisch, B ;

Steinmetz, A .

ATHEROSCLEROSIS, 1999, 144 (01) :177-184

[45] LOW HIGH-DENSITY-LIPOPROTEIN LEVEL IS ASSOCIATED WITH INCREASED RESTENOSIS RATE AFTER CORONARY ANGIOPLASTY [J].

SHAH, PK ;

AMIN, J .

CIRCULATION, 1992, 85 (04) :1279-1285

[46] Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins - An idea whose time for testing is coming, Part I [J].

Shah, PK ;

Kaul, S ;

Nilsson, J ;

Cercek, B .

CIRCULATION, 2001, 104 (19) :2376-2383

[47]

Slyper A, 2005, AM J CLIN NUTR, V81, P376

[48] Mechanism of action of fibrates on lipid and lipoprotein metabolism [J].

Staels, B ;

Dallongeville, J ;

Auwerx, J ;

Schoonjans, K ;

Leitersdorf, E ;

Fruchart, JG .

CIRCULATION, 1998, 98 (19) :2088-2093

[49] Effects of diet and exercise in men and postmenopausal women with low levels of HDL cholesterol and high levels of LDL cholesterol [J].

Stefanick, ML ;

Mackey, S ;

Sheehan, M ;

Ellsworth, N ;

Haskell, WL ;

Wood, PD .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (01) :12-20

[50] Arterial biology for the investigation of the treatment effects of reducing cholesterol (ARBITER) 2 - A double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins [J].

Taylor, AJ ;

Sullenberger, LE ;

Lee, HJ ;

Lee, JK ;

Grace, KA .

CIRCULATION, 2004, 110 (23) :3512-3517

← 1 2 3 4 5 6 →